Neomycin Sulfate

Specifications

1405-10-3CAS Number

248-770-9EC Number

(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol;sulfuric acidIUPAC Name

C23H48N6O17SChemical Formula

712.7 g/molMolecular Weight

NEOMYCIN SULFATE; Neomycin B sulfate; 1405-10-3; Neomycin sulphate; Mycifradin; Bykomycin; Neomix; Neomycin, sulfate (salt); Fradiomycin sulfate; Neo-Rx; Myciguent; Neobiotic; Neo-Fradin; CHEBI:53636; DTXSID10948247; USAF CB-19; Tuttomycin; Endomixin; Fraquinol; Myacine; Neosulf; Neomycin b, sulphate (salt); Neo-sol 50; (1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside sulfate; Sulfate, Framycetin; Neomycin sulfate (USP); Sulfate, Neomycin B; NEOMED 325; Vitacilina; Cicatrene; Graneodin; Neobacrin; Neoplex; Neovet; Neomycin Liquid; Biosol Liquid; Neosol-Oral; DTXSID4041074; Gppe nsl gel; Neomycin Ointment; NSC-757240; Neo-Sol; Antibiotic Ointment; First Aid Ointment; (1R,2R,3S,4R,6S)-4,6-diamino-2-((3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl)oxy)-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside sulfate; NEOSOL; Neosol Soluble Powder; NeoMed Soluble Powder; Family Care Antibiotic; Neomycin Oral Solution; Neomycin Sulfate 325; RefChem:55696; Neo 200 Oral Solution; First Aid Only Antibiotic; Roosin Neomycin Antibiotic; 057Y626693; Water-jel Neomycin Antibiotic; Single Antibiotic With Neomycin; CHEBI:31635; DTXCID501768698; First Aid Only Neomycin Antibiotic; POMADA SULFA FIRST AID ANTIBIOTIC; Family Care Triple Antibiotic Pain Relief; First Aid Only Antibiotic Neomycin Sulfate; Vitacilina Neomycin Sulfate First Aid Antibiotic; Biosol Sterile Solution, Biosol Sterile Solution 50 mg; Neomix 325 Soluble Powder, Neomix AG 325 Soluble Powder; Neomix Ag 325 Medicated Premix, Neomix 325 Medicated Premix; 215-773-1; Framycetin sulfate; 28002-70-2; Framycin sulfate; Neomycin B sulphate; Neomycin B, sulfate (salt); Neomycin trisulfate salt hydrate; Neomycin Trisulfate Hydrate; 25389-98-4; C23H48N6O17S; MFCD00150827; (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol;sulfuric acid; (2S,3S,4R,5R,6R)-5-Amino-2-(aminomethyl)-6-(((2R,3S,4R,5S)-5-(((1R,2R,3S,5R,6S)-3,5-diamino-2-(((2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-6-hydroxycyclohexyl)oxy)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl)oxy)tetrahydro-2H-pyran-3,4-diol sulfate; (2S,3S,4R,5R,6R)-5-Amino-2-(aminomethyl)-6-(((2R,3S,4R,5S)-5-(((1R,2R,3S,5R,6S)-3,5-diamino-2-(((2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-6-hydroxycyclohexyl)oxy)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl)oxy)tetrahydro-2H-pyran-3,4-diol xsulfate; EINECS 248-770-9; MFCD00077833; O-2,6-Diamino-2,6-dideoxy-ss-L-idopyranosyl-(1?3)-O-ss-D-ribofuranosyl-(1?5)-O-[2,6-diamino-2,6-dideoxy-a-D-glucopyranosyl-(1?4)]-2-deoxy-D-streptamine sulfate (salt) (9CI); Neomycin B, sulfate (salt) (8CI); Framycetin sulfate; Framycin sulfate; Isofra (TN); Neomycin sulfate CRS; Framycetin sulfate CRS; starbld0006229; 2nd International Standard for Neomycin B; (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol;sulfuric acid; SCHEMBL373681; MSK7710B; MSK7710B-100AW; MSK7710B-100MW; HMS2095O18; HMS3712O18; MSK7710B-1000AW; MSK7710B-1000MW; EBC-98150; AKOS016340327; AN10534; CCG-220158; KS-1358; D-Streptamine, O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-3)-O-beta-D-ribofuranosyl-(1-5)-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4))-2-deoxy-, sulfate (salt); Neomycin sulfate 100 microg/mL in Water; SY072627; Third International Standard for Neomycin; Framycetin sulfate (Neomycin B sulfate) RS; F0649; N1755; NS00083866; Neomycin sulfate for microbiological assay CRS; D07994; N-2515; Q27124126; Neomycin sulfate Solution in Methanol/Water, 1000ug/mL; Neomycin sulfate Solution in Methanol/Water, 100ug/mL; Neomycin sulfate Solution in Acetonitrile/Water, 1000ug/mL; Neomycin sulfate Solution in Acetonitrile/Water, 100ug/mL; Neomycin trisulfate, Antibiotic for Culture Media Use Only; D-Streptamine, O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-->3)-O-beta-D-ribofuranosyl-(1-->5)-O-[2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-->4)]-2-deoxy-, sulfate (1:1); Sulfuric acid--(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside (1/1)Synonyms